当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Reza Amani
The combination of declining figures of new medicine blessings and rising prohibitive costs poses serious challenges to medicine discovery. The arrival of combinatorial chemistry has given rise to renewed stopgap of adding the success rate of new chemical realities (NCEs). But indeed this scientific development has not bettered the success rate of new medicine discovery. This script has allowed us to develop a new approach to integrated medicine discovery where Ayurvedic wisdom can interact with medicine discovery from botanical sources. The first step in medicine discovery involves NCE identification. NCEs can be attained by chemical conflation or insulated from natural products by biologically active separation. The source of numerous new medicines and active constituents in medicinal comes from natural products. A starting point for discovering new factory- grounded drugs is to use Ayurvedic wisdom, traditional proved uses, undocumented ethnical uses, and expansive literature review to identify suitable campaigners. A frequence analysis of the factors of recently proved phrasings and an analysis of their Ayurvedic parcels will allow the selection of suitable seeker shops for separation grounded on their natural exertion. We can give you a complete idea about the dominance of Vedic parcels. Integrating the wisdom of Ayurveda into pharmaceutical exploration requires a paradigm shift in the birth process from successional to resembling birth. Bioassay- grounded separation of linked shops yields formalized excerpts or insulated bioactive medicinal composites as new medicines. This integrated approach improves medicine discovery success rates and saves cost and time.